FDA Approved: LANTHANUM CARBONATE — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva's lanthanum carbonate generic product for reducing phosphate levels in patients with end-stage renal disease on dialysis. This approval is und…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease
• Hyperphosphatemia

Drugs mentioned

• LANTHANUM CARBONATE (lanthanum carbonate)

Snippet

ORIG AP for LANTHANUM CARBONATE (LANTHANUM CARBONATE)